Clinical Trials Browser

Phase 1/2 × Recurrent Extensive Stage Small Cell Lung Carcinoma × Temozolomide × Clear all

NCT05728619 2023-09-28

HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer

Phase 1/2 Unknown

Recurrent Extensive Stage Small Cell Lung Carcinoma